Stocks were again staging a gain on Tuesday. Investors are moving away from the belief that this is a raging bull market and are looking for individual names in a stock picker’s market. 24/7 Wall St. reviews dozens of analyst research reports each morning to find new ideas for our readers. Some of the analyst reports cover stocks to buy, while others cover stocks to sell or stocks to avoid.
Credit Suisse panned its allocation to U.S. stocks in its fresh global allocation changes. Also, Goldman Sachs has slightly raised its S&P 500 target. Also, here are the four stocks that dominated the Dow Jones Industrial Average gains on Monday.
These are this Tuesday’s top analyst upgrades, downgrades and initiations from Wall Street firms.
Applied Materials Inc. (NASDAQ: AMAT) was raised to Buy from Neutral with a $25 price target (versus a $23.06 close) at B. Riley.
Citigroup Inc. (NYSE: C) was reiterated as Outperform and the price target was raised to $68 at Oppenheimer.
Kimberly-Clark Corp. (NYSE: KMB) was raised to Neutral from Sell at Goldman Sachs.
Kite Pharma Inc. (NASDAQ: KITE) was started as Buy with a $31 price target (versus a $24.05 close) at Stifel Nicolaus. Jefferies started it with a Buy rating and $35 price target. Credit Suisse started it with an Outperform rating and $34 price target.